China Traditional Chinese Medicine Holdings Co. Limited Stock price

Equities

570

HK0000056256

Pharmaceuticals

Market Closed - Hong Kong S.E. 04:08:03 2024-03-28 am EDT 5-day change 1st Jan Change
4.28 HKD -0.47% Intraday chart for China Traditional Chinese Medicine Holdings Co. Limited -1.38% +8.91%

Financials

Sales 2023 18.12B 2.51B 19.62B Sales 2024 * 22.64B 3.13B 24.51B Capitalization 20B 2.77B 21.65B
Net income 2023 1.28B 178M 1.39B Net income 2024 * 1.43B 197M 1.54B EV / Sales 2023 0.99 x
Net Debt 2023 * 1.24B 172M 1.35B Net Debt 2024 * 1.88B 260M 2.04B EV / Sales 2024 * 0.97 x
P/E ratio 2023
14 x
P/E ratio 2024 *
14 x
Employees 17,303
Yield 2023 *
1.89%
Yield 2024 *
2.9%
Free-Float 67.54%
More Fundamentals * Assessed data
Dynamic Chart
China Traditional Chinese Medicine Posts 94% Profit Growth in 2023 MT
China Traditional Chinese Medicine Holdings Co. Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
China Traditional Chinese Medicine Holdings Co. Limited Announces Re-Designation of CHENG Xueren from Managing Director to Non-Executive Director CI
China Traditional Chinese Medicine Holdings Co. Limited Announces Board Changes CI
China Traditional Chinese Medicine's Stock Bolts on Privatization Offer MT
China stocks extend gains led by coal, AI; HK shares up RE
Hong Kong Stocks Hover Near Two-Month Highs Amid Mixed Corporate Earnings MT
China stocks jump with AI shares leading on Nvidia forecast; HK shares flat RE
Sinopharm offers to take China-TCM private in nearly $3 bln deal RE
Sinopharm Common Wealth Company Limited entered into a scheme of arrangement to acquire 67.54% stake in China Traditional Chinese Medicine Holdings Co. Limited for HKD 15.6 billion. CI
China Traditional Chinese Medicine Holdings Forecasts Up to 95% Surge in 2023 Profit; Shares Rise 4% MT
China Traditional Chinese Medicine Holdings Co. Limited Provides Preliminary Unaudited Consolidated Earnings Guidance for the Year Ended 31 December 2023 CI
China Traditional Chinese Medicine Holdings Co. Limited Reports Earnings Results for the Half Year Ended June 30, 2023 CI
China Traditional Chinese Medicine Holdings Co. Limited Announces Resignation of Kui Kaipin as Non-Executive Director, with Effect from August 29, 2023 CI
China Traditional Chinese Medicine's Profit to Climb Up to 55% in H1; Shares Up 3% MT
More news
1 day-0.47%
1 week-1.38%
Current month-0.93%
1 month-0.93%
3 months+9.18%
6 months+18.89%
Current year+8.91%
More quotes
1 week
4.27
Extreme 4.27
4.34
1 month
4.27
Extreme 4.27
4.38
Current year
2.80
Extreme 2.8
4.38
1 year
2.80
Extreme 2.8
4.68
3 years
2.62
Extreme 2.62
6.74
5 years
2.62
Extreme 2.62
6.74
10 years
2.62
Extreme 2.62
7.57
More quotes
Managers TitleAgeSince
Director of Finance/CFO 58 21-09-02
Chief Tech/Sci/R&D Officer - -
Director/Board Member 60 18-12-23
Members of the board TitleAgeSince
Director/Board Member 71 13-02-04
Director/Board Member 67 13-11-24
Director/Board Member 50 22-11-18
More insiders
Date Price Change Volume
24-03-28 4.28 -0.47% 36 330 074
24-03-27 4.3 -0.23% 21,256,000
24-03-26 4.31 0.00% 24,489,000
24-03-25 4.31 -0.23% 27,097,600
24-03-22 4.32 -0.46% 22,963,000

Delayed Quote Hong Kong S.E., March 28, 2024 at 04:08 am EDT

More quotes
China Traditional Chinese Medicine Holdings Co. Limited is principally engaged in the manufacture and sales of traditional Chinese medicine (TCM). The Company operates through 12 subsidiaries, including Sinopharm Group Dezhong (Foshan) Pharmaceutical Co., Ltd., Sinopharm Group Feng Liao Xing (Foshan) Pharmaceutical Co., Ltd., Sinopharm Group Guangdong Medi-World Pharmaceutical Co., Ltd., Sinopharm Group Luya (Shandong) Pharmaceutical Co., Ltd., Sinopharm Group Feng Liao Xing (Foshan) Medicinal Material & Slices Co., Ltd., Foshan Winteam Pharmaceutical Sales Company Limited, Sinopharm Group Tongjitang (Guizhou) Pharmaceutical Co., Ltd., Sinopharm Group Jingfang (Anhui) Pharmaceutical Co., Ltd., Sinopharm Group Longlife (Guizhou) Pharmaceutical Co., Ltd., Qinghai Pulante Pharmaceutical Co., Ltd., Guizhou Zhongtai Biological Technology Company Limited and its subsidiaries and Jiangyin Tianjiang Pharmaceutical Co., Ltd. and its subsidiaries.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
3.972 CNY
Average target price
4.166 CNY
Spread / Average Target
+4.88%
Consensus

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock China Traditional Chinese Medicine Holdings Co. Limited - Hong Kong S.E.